InvestorsHub Logo
Followers 277
Posts 32512
Boards Moderated 0
Alias Born 11/14/2013

Re: flipper44 post# 682077

Friday, 03/29/2024 10:41:09 AM

Friday, March 29, 2024 10:41:09 AM

Post# of 691352
Just one last comment on that Car-T trial. If you subtract the patients that were not GBM (Aka Grade 3 and/or idh mutation) there was only one possible partial/complete tumor response, and Senti has analyzed the problems with that one, aka: at best two to three month tumor response, but even that might be questionable.

Note: 25% or more in that CarT trial did not have GBM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News